NDAINHALATIONGAS
Approved
Aug 2013
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 9h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OXYGEN, USP (OXYGEN/NITROGEN 25/75) is a respiratory gas mixture approved as an inhalation product for medical use. The product is a standardized gas formulation delivered via inhalation route. It is used in clinical settings where controlled oxygen delivery is therapeutically indicated.
Peak
Mature product in peak lifecycle phase suggests stable, maintenance-focused commercial operations with established market presence.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on OXYGEN, USP offers stability in a mature product with established market presence and limited innovation demands. Career growth depends on operational excellence, supply chain optimization, and customer relationship management rather than clinical or breakthrough development activities.
Supply Chain ManagerRegulatory Affairs Specialist
Worked on OXYGEN, USP at Universal Cells? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.